120 related articles for article (PubMed ID: 8208061)
21. Coexistence of three tachykinin receptors coupled to Ca++ signaling pathways in intestinal muscle cells.
Hellstrom PM; Murthy KS; Grider JR; Makhlouf GM
J Pharmacol Exp Ther; 1994 Jul; 270(1):236-43. PubMed ID: 8035320
[TBL] [Abstract][Full Text] [Related]
22. Tachykinin antagonist I: Specific, competitive and tissue-selective neurokinin B antagonists on contractile activity in smooth muscles.
Hashimoto T; Uchida Y; Naminohira S; Sakai T
Jpn J Pharmacol; 1987 Dec; 45(4):570-3. PubMed ID: 3481842
[TBL] [Abstract][Full Text] [Related]
23. SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist.
Anthes JC; Chapman RW; Richard C; Eckel S; Corboz M; Hey JA; Fernandez X; Greenfeder S; McLeod R; Sehring S; Rizzo C; Crawley Y; Shih NY; Piwinski J; Reichard G; Ting P; Carruthers N; Cuss FM; Billah M; Kreutner W; Egan RW
Eur J Pharmacol; 2002 Aug; 450(2):191-202. PubMed ID: 12206858
[TBL] [Abstract][Full Text] [Related]
24. Selective agonists of NK-2 binding sites highly active on rat portal vein (NK-3 bioassay).
Chassaing G; Lavielle S; Loeuillet D; Robilliard P; Carruette A; Garret C; Beaujouan JC; Saffroy M; Petitet F; Torrens Y
Neuropeptides; 1991 Jun; 19(2):91-5. PubMed ID: 1658676
[TBL] [Abstract][Full Text] [Related]
25. Effect of YM-44781, YM-44778 and YM-49598, novel tachykinin antagonists, in a drug-induced bladder contraction model.
Choppin A; Groke G; Bringas A; Stepan G; Dillon MP
Pharmacology; 2002 May; 65(2):96-102. PubMed ID: 11937780
[TBL] [Abstract][Full Text] [Related]
26. Dactinomycin is a competitive neurokinin-2 receptor antagonist.
Delay-Goyet P; Lundberg JM
Biochem Biophys Res Commun; 1991 Nov; 180(3):1342-9. PubMed ID: 1659413
[TBL] [Abstract][Full Text] [Related]
27. Further evidence that central tachykinin NK-1 receptors mediate the inhibitory effect of tachykinins on angiotensin-induced drinking in rats.
Polidori C; Ciccocioppo R; De Caro G; Massi M
Peptides; 1998; 19(1):149-55. PubMed ID: 9437747
[TBL] [Abstract][Full Text] [Related]
28. Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat.
Wagner U; Fehmann H; Bredenbröker D; Klüber D; Lange A; Wichert P
Neuropeptides; 1999 Feb; 33(1):55-61. PubMed ID: 10657472
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity of tachykinin NK-2 receptors in rabbit, guinea-pig and human smooth muscles.
Maggi CA; Giuliani S; Patacchini R; Quartara L; Rovero P; Renzetti AR; Mizrahi J; Giachetti A
Neuropeptides; 1992 Nov; 23(3):181-6. PubMed ID: 1335134
[TBL] [Abstract][Full Text] [Related]
30. Affinity of R 396, an NK-2 tachykinin receptor antagonist, for NK-2 receptors in preparations from different species.
Maggi CA; Patacchini R; Astolfi M; Rovero P; Giachetti A; Van Giersbergen PL
Neuropeptides; 1992 Jun; 22(2):93-8. PubMed ID: 1328923
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological activity of N-methylated analogues of neurokinin A.
Rovero P; Pestellini V; Patacchini R; Santicioli P; Maggi CA; Meli A
Neuropeptides; 1987; 10(4):355-9. PubMed ID: 2829053
[TBL] [Abstract][Full Text] [Related]
32. Actinomycin D is a competitive and selective antagonist at NK2 tachykinin receptors.
Patacchini R; Astolfi M; Brown MC; Maggi CA
Neuropeptides; 1991 Oct; 20(2):109-14. PubMed ID: 1665895
[TBL] [Abstract][Full Text] [Related]
33. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.
Maggi CA; Patacchini R; Eglezos A; Quartara L; Giuliani S; Giachetti A
Br J Pharmacol; 1992 Sep; 107(1):27-33. PubMed ID: 1384907
[TBL] [Abstract][Full Text] [Related]
34. Use of selective antagonists for further characterization of tachykinin NK-2, NK-1 and possible "septide-selective" receptors in guinea pig bronchus.
Zeng XP; Burcher E
J Pharmacol Exp Ther; 1994 Sep; 270(3):1295-300. PubMed ID: 7523658
[TBL] [Abstract][Full Text] [Related]
35. Potencies of agonists acting at tachykinin receptors in the oestrogen-primed rat uterus: effects of peptidase inhibitors.
Fisher L; Pennefather JN
Eur J Pharmacol; 1997 Sep; 335(2-3):221-6. PubMed ID: 9369377
[TBL] [Abstract][Full Text] [Related]
36. N-terminal truncated analogs of men 10376 as tachykinin NK-2 receptor antagonists.
Quartara L; Patacchini R; Giuliani S; Renzetti AR; Rovero P; Maggi CA
Life Sci; 1992; 51(25):1929-36. PubMed ID: 1333561
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
[TBL] [Abstract][Full Text] [Related]
38. Competitive antagonists discriminate between NK2 tachykinin receptor subtypes.
Maggi CA; Patacchini R; Giuliani S; Rovero P; Dion S; Regoli D; Giachetti A; Meli A
Br J Pharmacol; 1990 Jul; 100(3):589-92. PubMed ID: 2167737
[TBL] [Abstract][Full Text] [Related]
39. Importance of the leucine side-chain to the spasmogenic activity and binding of substance P analogues.
Lavielle S; Chassaing G; Brunissen A; Rodriguez M; Martinez J; Convert O; Carruette A; Garret C; Petitet F; Saffroy M
Int J Pept Protein Res; 1993 Sep; 42(3):270-7. PubMed ID: 7693605
[TBL] [Abstract][Full Text] [Related]
40. Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems.
Floch A; Fardin V; Cavero I
Br J Pharmacol; 1994 Mar; 111(3):759-68. PubMed ID: 7517328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
